 |
인쇄하기
취소
|
Leadpharm to enter Kosdaq bourse via Esseltec acquisition.
Leadpharm, a pharmacy chain franchise company, is trying to enter the Kosdaq market via a detour channel.
According to the electronic public notice of Financial Supervisory Service (FSS), Leadpharm made a contract to purchase 800 thousand stocks of Esseltec, an LCD manufacturer, at 3 billion won and to take over the convertible bond amounted to 6.5 billion won.
By such merger Leadpharm ma...
According to the electronic public notice of Financial Supervisory Service (FSS), Leadpharm made a contract to purchase 800 thousand stocks of Esseltec, an LCD manufacturer, at 3 billion won and to take over the convertible bond amounted to 6.5 billion won.
By such merger Leadpharm ma...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.